90 related articles for article (PubMed ID: 8397459)
1. [Nuclear medicine studies of tissue concentration and hemodynamic effects of retrograde intravenous pressure infusions].
Partsch H; Jochmann W; Mostbeck A; Hirschl M
Wien Med Wochenschr; 1993; 143(7-8):172-6. PubMed ID: 8397459
[TBL] [Abstract][Full Text] [Related]
2. [Systemic infusion therapy versus retrograde intravenous perfusion: comparative results in patients with diabetic neuropathic plantar ulcer].
Seidel C; Bühler-Singer S; Richter UG; Hornstein OP
Wien Med Wochenschr; 1993; 143(7-8):201-3. PubMed ID: 8379178
[TBL] [Abstract][Full Text] [Related]
3. Drug therapy of diabetic neuropathic foot ulcers: transvenous retrograde perfusion versus systemic regimen.
Seidel C; Richter UG; Bühler S; Hornstein OP
Vasa; 1991; 20(4):388-93. PubMed ID: 1776352
[TBL] [Abstract][Full Text] [Related]
4. [Pioneer experience with buflomedil in the form of retrograde venous pulse therapy for treatment of ischemia and severe extremity infections].
Cavini-Ferreira PC
Wien Med Wochenschr; 1993; 143(7-8):193-4. PubMed ID: 8379175
[TBL] [Abstract][Full Text] [Related]
5. [Urokinase in refractory lower leg ulcers: therapy with retrograde intravenous pressure infusion].
Partsch H; Jochmann W
Wien Med Wochenschr; 1993; 143(7-8):187-90. PubMed ID: 8379173
[TBL] [Abstract][Full Text] [Related]
6. A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication.
Van den Brande P; Maurel A
Angiology; 1998 Feb; 49(2):105-14. PubMed ID: 9482510
[TBL] [Abstract][Full Text] [Related]
7. [Disordered cutaneous microcirculation in diabetic neuropathic foot ulcer. Is modification by retrograde transvenous perfusion therapy possible?].
Bühler-Singer S; Hiller D; Boateng B; Albrecht HP; Seidel C; Hornstein OP
Hautarzt; 1995 Jun; 46(6):400-5. PubMed ID: 7642383
[TBL] [Abstract][Full Text] [Related]
8. [Retrograde intravenous perfusion: technique and different variants].
Jochmann W; Partsch H
Wien Med Wochenschr; 1993; 143(7-8):167-70. PubMed ID: 8379168
[TBL] [Abstract][Full Text] [Related]
9. Effects of buflomedil on microvascular disorders in diabetic patients.
Le Dévéhat C; Vimeux M; Bondoux G; Khodabandehlou T
Blood Vessels; 1991; 28 Suppl 1():38-43. PubMed ID: 1932765
[TBL] [Abstract][Full Text] [Related]
10. [Retrograde venous perfusion in treatment of diabetic gangrene].
Nilius J; von Bary S
Vasa Suppl; 1991; 32():420-1. PubMed ID: 1771548
[No Abstract] [Full Text] [Related]
11. [Malum perforans diabeticorum: treatment with controlled circulatory blockade and regional intravenous administration of antibiotics].
Acevedo A; Decinti E; Toledo L; Pérez O
Wien Med Wochenschr; 1993; 143(7-8):195-8. PubMed ID: 8379176
[TBL] [Abstract][Full Text] [Related]
12. [Retrograde venous perfusion (RVP in ulcero-mutilating neuropathy].
Brunner M; Göring HD
Hautarzt; 2001 Oct; 52(10 Pt 2):956-61. PubMed ID: 11715393
[TBL] [Abstract][Full Text] [Related]
13. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
Joffre F; Meites G; Rousseau H; Staffin C; Allaert FA; Pelat P
Ann Radiol (Paris); 1994; 37(3):239-44. PubMed ID: 8092756
[TBL] [Abstract][Full Text] [Related]
14. Dialysis clearance of buflomedil in hemodialysed patients.
Rey E; Moynot A; d'Athis P; Pello JY; Maurel A; Frydman MO; Buisson C; Olive G
Arzneimittelforschung; 1996 May; 46(5):492-5. PubMed ID: 8737633
[TBL] [Abstract][Full Text] [Related]
15. Disturbances of cutaneous microcirculation in patients with diabetic legs: additional parameters for a new therapeutic concept?
Bühler-Singer S; Hiller D; Albrecht HP; Seidel C; Hornstein OP
Acta Derm Venereol; 1994 Jul; 74(4):250-6. PubMed ID: 7976079
[TBL] [Abstract][Full Text] [Related]
16. [Technical concepts of retrograde venous perfusion with fluorescein].
Scheffler A; Friedrichs EA; Rieger H
Wien Med Wochenschr; 1993; 143(7-8):177-8. PubMed ID: 8379169
[TBL] [Abstract][Full Text] [Related]
17. [Placebo controlled, double-blind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease].
Stiegler H; Diehm C; Grom E; Martin M; Mörl H; Rudofsky G; Vogelberg KH
Vasa Suppl; 1992; 35():164-6. PubMed ID: 1481031
[No Abstract] [Full Text] [Related]
18. Prostaglandin E1 increases the blood flow rate of saphenous vein grafts in patients undergoing off-pump coronary artery bypass grafting.
Zhao L; Lu J; Wang C; Zhao W; Qing E; Ma J
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1208-11. PubMed ID: 24090805
[TBL] [Abstract][Full Text] [Related]
19. Cytostatic lung perfusion results in heterogeneous spatial regional blood flow and drug distribution: evaluation of different cytostatic lung perfusion techniques in a porcine model.
Krueger T; Kuemmerle A; Kosinski M; Denys A; Magnusson L; Stupp R; Delaloye AB; Klepetko W; Decosterd L; Ris HB; Dusmet M
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):304-11. PubMed ID: 16872954
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of atrial natriuretic peptide administration on peripheral arterial diseases.
Park K; Itoh H; Yamahara K; Sone M; Miyashita K; Oyamada N; Sawada N; Taura D; Inuzuka M; Sonoyama T; Tsujimoto H; Fukunaga Y; Tamura N; Nakao K
Endocrinology; 2008 Feb; 149(2):483-91. PubMed ID: 17991722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
